Ghost Tree Capital’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Ghost Tree Capital’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-65,000	Closed	-$5.03M	–	109
2015 Q2	$5.03M	Buy	+65,000	New	+$4.26M	1.63%	25
2014 Q3	–	Sell	-150,000	Closed	-$2.66M	–	99
2014 Q2	$2.66M	Buy	150,000 +130,000	+650%	+$2.09M	1.88%	19
2014 Q1	$400K	Buy	+20,000	New	+$388K	0.24%	61

Other funds holding ANAC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Rho Capital Partners New York $20.4M AUM

Ghost Tree Capital's ANAC Position: Q3 2015 in Review

Ghost Tree Capital sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q3 2015, closing a stake of 65,000 shares — an estimated $5.03M sold.

Ghost Tree Capital first reported a position in ANAC in Q1 2014 and held it in 3 quarters. The position peaked at $5.03M in Q2 2015. 213 funds tracked by Wall St. Rank hold ANAC as of Q3 2015.

Ghost Tree Capital reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q3 2015 after selling out during the quarter.
Ghost Tree Capital sold 65,000 ANACOR PHARMACEUTICALS INC COM shares in Q3 2015, an estimated $5.03M.
Ghost Tree Capital first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 3 quarters.
Ghost Tree Capital's ANACOR PHARMACEUTICALS INC COM position peaked at $5.03M in Q2 2015.
213 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q3 2015.

Based on Ghost Tree Capital's 13F filing for Q3 2015, filed 16 Nov 2015.